The expression of the collagen a,(I) gene in activated stellate cells plays an important role during liver fibrogenesis.
Introduction
Collagen type I, which forms large collagen fibers, is a major component of the excessive extracellular matrix protein in cirrhosis ( 1, 2) . In hepatic fibrogenesis, and following the acquisition of an activated phenotype (3), stellate cells display a high level of collagen type I expression (4) . Therefore, the regulation of the type I collagen gene in hepatic stellate cells is crucial in understanding the pathogenesis of fibrosis in chronic liver disease (5, 6) .
Although the molecular mechanisms responsible are unknown, the increased production of collagen al(I) in liver inAddress correspondence to Karl Houglum, Department of Medicine (911 1-D), University of California, San Diego, San Diego, CA 92161. Received for publication 18 April 1995 and accepted in revised form 26 July 1995. jury is mainly a result of an enhanced collagen gene transcription (7, 8) . The factors known to stimulate collagen gene transcription include acetaldehyde (9) , lipid peroxidation and its products (10, 11) , and transforming growth factor-f3I (TGF/ I) (12) . Several lines of investigation have provided evidence indicating that aldehyde-protein adducts, including products of lipid peroxidation, and TGF31, modulate collagen gene expression (9) (10) (11) (12) and may be a link between tissue injury and fibrosis (13) (14) (15) (16) .
At least in part, this cell-specific gene transcription is controlled by diffusible positive transcription factors that are, themselves, enriched in particular cell types (17) . By binding specifically to their DNA recognition sites within promoter and/ or enhancer regions, such proteins can augment the frequency of transcription initiation of their target genes (18) . Positive and negative regulatory elements have been identified in the promoter and first intron of the collagen a,(I) gene (19, 20) . In addition, we identified an enhancer element (Col E-1 [-370 to -344 bp]) that stimulates transcription in both the forward and reverse orientations, when placed before either a heterologous or homologous promoter (21) . However, these cis-acting elements cannot explain the high expression of the collagen a, (I) gene in different cell types.
In studies of transgenic animals the critical cis-acting element of the collagen al (I) gene has been located for skin and tail in the -2300 to -440-bp region (22, 23) , and for bone between -2296 and -1672 bp (24) . Therefore, in these cell types with high levels of expression of the collagen al (I) gene, a key regulatory region excludes the -0.44-kb 5' region. In the liver, the element responsive to CC14, a fibrogenic hepatotoxin (4, 8) that activates stellate cells (3) , is present in a human transgene that contains the structural gene, 1.6 kb of promoter and 20 kb of 3' untranslated region (25) . Thus, the cis-element(s) and trans-acting factor(s) necessary (28, 29) , using the riboprobe for exon 5 of the human growth hormone gene (22) . This and other collagen riboprobes have been used successfully for in situ hybridization or RNase protection assays of the collagen a,(I) gene (15, 16, 27 (30, 31) . The transgenic founder mice were then mated to normal F. hybrids to establish transgenic mouse lines. Transgenic animals were studied in an animal model of lipid peroxidation and fibrogenesis, CC14 intoxication, as reported previously (8, 15, 34) . Transgenic animals (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) grams) received a single dose of CC14
in mineral oil 1:1 (vol/vol) at a dose of 3 ml/kg or mineral oil, and processed as described previously (15) . After 48 h, animals were euthanized, and the liver was utilized for RNA isolation, immunohistochemistry and stellate cell isolation as described previously (15, (29) (30) (31) .
Gel retardation experiments. Gel retardation assays were performed as discussed previously (21, 29) . Double-stranded oligonucleotides were end-labeled with [32P] y-ATP and T4 polynucleotide kinase by the forward reaction (21 ) . Oligonucleotides were used as follows (sense orientation shown): footprint 1 (5' CTAGCTGATTGGCTGGGGGCC-GGGCT 3') (21); NFl (5' AITJTGGCYTGAAGCCAATATG 3') (Stratagene); SPI (5' GATCGATCGGGGCGGGGCGATC 3 ') (Stratagene); and albumin D site (5' TGGTATGAT'ITITGTAATGGGG 3') (21) .
Statistical analysis. Results are expressed as mean (±SEM). Either the Student t or the Fisher's exact test (two-tailed) was used to evaluate the differences of the means between groups; a P value of < 0.05 was considered significant.
Results
We first analyzed the expression of the collagen a I(I) gene in the liver following the induction of hepatic injury and lipid peroxidation by the hepatotoxin, CCl4. Transgenic mice containing various regulatory regions of the human collagen al (I) gene were treated with CC14 to induce hepatic lipid peroxidation and fibrogenesis as described previously (15) . The degree of hepatocellular necrosis in these animals was similar to that described previously for rats (15) , judging by liver staining with hematoxylin/eosin (not shown), and by the release of liver enzymes into the blood (serum alanine transaminase: 2004+254 vs 34±18 IU/ml; P < 0.05). Similarly, the degree of lipid peroxidation was comparable to that reported by us in rats treated with CC14 or overloaded with iron (15, 16) . Protein adducts with malondialdehyde, a product of lipid peroxidation, were detected using specific antibodies against the malondialdehyde-lysine epitopes, as reported previously (15, 16, 30) . In contrast to the livers of control animals ( Fig. 1 A) , enhanced lipid peroxidation occurred in mice treated with CC14 at 48 h in zones 2 and 3 of the hepatic acinus ( Fig. 1 B) , as reported for rats ( 15) .
The expression of various human collagen a1l(l)-human growth hormone (hGH) transgenes (22) was studied in the liver (see Fig. 2 ). Collagen aI (I) and hGH mRNA were analyzed by an RNase protection assay, and simultaneous measurement of GAPDH was used as an internal standard (35). Expression of GAPDH per microgram total RNA was only slightly increased following CCl4-treatment (P > 0.05; NS). In addition, the confounding variable of a different transgene copy number when various lines were compared (22) was avoided by comparing expression under baseline and activated conditions in the same transgenic line (see Figs. 3 and 4) . The steady state pool of hGH mRNA (exons 4 and 5) was consistently stimulated by CC14, and in parallel to the endogenous mouse collagen al(I) gene, whether the collagen a1l(I) regulatory region contained the -0.44 or -2.3-kb 5' flanking sequence, and in the presence or absence (AI) of the first intron (bases +292 to + 1607) (Figs. 3 and 4) . Because of these unexpected results, and in order to confirm these findings, another transgenic line of -440 COL-hGH (line A) was studied. These animals also responded to CCl4 intoxication with an increase in hGH transgene expression in the liver comparable to the stimulation of the endogenous collagen a I(I) gene (Figs. 3 and 4) . (Fig. 1 D) , and expressed a quantity of a-smooth muscle actin (Lee et al., unpublished observations), similar to that in stellate cells cultured on plastic for 10 d (36, 37) . In contrast, stellate cells from control animals had a quiescent phenotype (Fig. 1 C) shaded bar, and Fig. 4) , and the increase paralleled the expression of the endogenous collagen a,1(I) gene in these freshly isolated cells, which was greater than sixfold (Fig. 4) . Furthermore, the level of expression of the transgene in freshly isolated stellate cells, suggests that these cells are mainly responsible for the increased expression of these transgenes in the liver of CCl4-treated animals. As expected, the collagen a I(I) gene and the -440 COL-hGH transgene were expressed at higher levels in freshly isolated hepatic stellate cells than in the entire liver, given that the lower contribution, per cell, of other cell populations toward collagen gene expression (4), would dilute the stellate cell contribution. The activation of stellate cells in the liver during liver injury and fibrogenesis is characterized by a stellate morphology and by the expression of a-smooth muscle actin (3). These prototypical changes of stellate cell activation are also observed when Representative examples of the RNase protection assay comparing the expression of hGH minigenes with the endogeneous collagen a1I (I) gene in CCl4-induced hepatic fibrogenesis. Samples were obtained as described in Fig. 3 . mRNAs for hGH, GADPH and collagen a1I (I) were detected. The specific activity of the probes was identical for each control (-) and experimental (+CC14) pair.
-I Figure 5 . However, following stellate cell activation by culturing these cells on plastic for ten days, there was a dramatic increase in the expression of collagen a I (I) gene. The expression of collagen act (I) in activated stellate cells (day 10) was about 40-fold higher than in quiescent stellate cells (day 1) (Fig. 5) . The endogenous collagen gene expression was paralleled by the transcriptional activation of the -440 COL-hGH transgene (Fig. 5) . Thus, the transactivation of collagen a1l(I) gene expression in cultured, activated stellate cells requires only -0.44 kb of the 5' regulatory region, and resembles the regulation of these cells in the intact animal after CCl4 treatment. As expected, there was also a large stimulation of the expression of the -2300 COL-hGH transgene in activated stellate cells when compared to quiescent stellate cells (Fig. 5) . The apparent, reduced expression of this transgene in activated cultured stellate cells, in comparison with the -440 COL-hGH, is due mainly to a higher level of induction in quiescent stellate cells, and suggests a mild but spurious activation of the -2300 COLhGH under these conditions. Indeed, the hGH mRNA/GAPDH mRNA ratio (expressed in densitometric units) for the -440 COL-hGH and -2300 COL-hGH mRNAs in day 0 stellate cells, was 1.0 and 4.6, respectively. The comparable values for the -440 COL-hGH and -2300 COL-hGH mRNAs in day 10 stellate cells, were 40.3 and 106, respectively. The variable baseline expression of the transgenes is related to copy number and "leakiness" of the construct, and it is therefore less informative than the increase in expression following activation, as described previously (23 CCAAT binding proteins are thought to be important in the regulation of the collagen a I(I) gene because in human, rat, and mouse two highly conserved CCAAT binding sequences are present in the collagen a I(I) promoter sequence ( 19) . CBF is a CCAAT binding factor isolated from liver nuclear extracts which binds to both CCAAT sites (38) . Also, LAP, a bZIP transcription factor, binds to and activates transcription from the proximal CCAAT element (footprint 1 ;FPl ) (21 ) . Furthermore, NF-1 binds to both CCAAT box sites, and might play a role in collagen gene expression in fibroblasts (39) . For these reasons, we studied the binding affinity of nuclear proteins from quiescent and activated stellate cells to cis-acting elements of the collagen a I(I) promoter. As shown in Fig. 6 A (lane 4), nuclear extracts from activated stellate cells formed a complex with a [32P] -FP1 cognate DNA element (bp-82 to-103 of the collagen aI (I) gene). The formation of this DNA-protein complex was efficiently competed by FPl oligonucleotide, as expected, and by an NF1 oligonucleotide (lane 7). In contrast, neither LAP (albumin D site) (21) nor SPI cis-acting elements were able to disrupt the DNA-protein complex (lanes 6 and 8). Moreover, nuclear proteins from activated stellate cells formed a similar complex with a [32P]NFI oligonucleotide (Fig. 6 B,  lane 4) , which was competed by a FP1 oligonucleotide (lane 5) but not a D site oligonucleotide (lane 6). The different pattern of DNA-protein complexes produced by the binding of nuclear extracts from quiescent stellate cells to both [32P] FPI and [32p] NFI was also competed by FP1 oligonucleotides, indicating the binding of different or modified nuclear proteins to these sites. These results suggest that the proximal CCAAT element, and in particular the NFl cognate sequence, may be important in the increased transcription of the collagen a, (l) gene in activated stellate cells.
In addition, we analyzed the expression of the transgenes and collagen al (I) gene, in skin and tendon from these animals (Fig. 7) . As depicted in Fig 7, A and B , in skin and tendon the -2.3-kb region directs the transcription of the hGH reporter gene at much higher levels than does the -0.44-kb region. The expression of the -440 COL-hGH transgene was only 10-20% that of the -2300 COL-hGH transgene in skin and tendon. Moreover, the -2.3-kb region was required for the level of expression of the transgene to reflect closely the expression of the endogenous collagen al (I) (data not shown). Collectively, these data indicate that the -0.44-kb 5' region of the collagen al(I) gene contains the cis-element(s) critical for maximal trans-activation of this gene in the liver of animals during the induction of fibrogenesis, but not for maximal expression of the gene in skin and tendon.
Complementary information was obtained with another transgenic line of mice containing the ,3-galactosidase reporter gene driven by the mouse collagen al(I) promoter (-1627/ +110 bp) (see Fig. 2 ). The functional expression of the transgene was determined by slot blots of tail DNA probed with a 32P-labeled ,3-galactosidase gene fragment (not shown). Transgene expression was confirmed by ,f-galactosidase immunohistochemistry of cryostat sections of the tail (see below). This transgene was also activated in the liver by CC14 treatment, resulting in a marked increase in the expression of /3-galactosidase, as detected by immunofluorescence, almost exclusively in sinusoidal cells with the phenotype of activated stellate cells (Fig. 8, B and C) . No expression of the chimeric -1627 COL-P-galactosidase reporter gene was seen when the first antibody was omitted (not shown), or when transgenic animals were treated with mineral oil (Fig. 8 A) . This experiment supports our earlier conclusion that the first intron is not essential for high expression of the collagen al(I) gene in activated stellate cells (see Fig. 3 ).
As expected, the expression of the -1627 COL-,6-galactosidase transgene was negligible in skin ( Fig. 9 B) , since collagen gene expression in dermal fibroblasts has been shown to require the first intron (23) . However, expression of the -1627 COL-/3-galactosidase transgene was readily detected in tendon, indicating that the first intron is not required for collagen a I(I) gene expression in tendon fibroblasts (Fig. 9 B) . No expression was observed when the first antibody was omitted (Fig. 9 A) , or in nontransgenic animals (not shown). These findings suggest that the -1627/ + 1 10-bp region of the collagen aI (I) gene is sufficient to direct the expression of the 3-galactosidase transgene in tendon fibroblasts. Collectively, these data indicate that two different cis-regulatory regions direct cell-specific transcription of the collagen a, (I) gene; the -0.44-kb 5' region is sufficient in activated stellate cells, while the -2.3 to -0.44-kb region is required for maximal expression in skin and tendon fibroblasts.
Discussion
In this study, we have identified different regulatory regions of the collagen a, (I) gene that are activated in a cell-specific manner in either stellate cells or skin and tendon fibroblasts, and result in high levels of expression of the gene. Figure 9 . Expression of the -1627 COL-,f-galactosidase transgene in tendon. P-galactosidase was detected by immunohistochemistry using 3-galactosidase antibodies and avidin-biotin-alkaline phosphate labeled second antibodies (blue) ( x 100). Tail tissue was obtained from nontransgenic (A) and transgenic (B) animals.
bp 5' region is unable by itself to direct high level transcription of the collagen al (I) gene in skin or tendon fibroblasts.
In tissues with high expression of the collagen al(I) gene, the -0.44-kb 5' flanking sequence has previously been shown to be insufficient to direct expression of the gene. Krebsbach et al. (24) , found that in calvarial bone, the region between -2296 and -1672 bp of the collagen al (I) gene was indispensable for its expression. In addition, Bornstein and co-workers have reported (22, 23) that the region between -2.3 to -0.44-kb was necessary for collagen al(I) expression in skin and tail. Expression of the -440 COL-hGH transgene in the tail was about 10-fold lower than that of the -2300 COL-hGH transgene (22) . However in the tail, tendon contributes only a small percentage to the total RNA, and other tissue components of the tail (skin, bone, etc.), which do not express the -440 COLhGH transgene, could have diluted the contribution of tendon when whole tail is analyzed (22) . Our finding that the -0.44-kb 5' region is insufficient to direct maximal transcription of the hGH transgene in tendon fibroblasts, indicates that full expression of the collagen al (I) transgene requires the -2.3 to -0.44-kb region of the collagen gene.
Tissue-specific transcriptional control of the collagen a, (I) gene has been suspected, since the insertional mutation of the Moloney murine leukemia virus affects collagen expression in fibroblasts but not in odontoblasts (40) . This altered transcriptional activity of the collagen al (I) gene is probably the result of a change in chromatin conformation induced by the viral insertion (41) . Our finding of cell-specific cis-acting regulatory regions within the collagen al (I) 5' regulatory region has another precedent. The a-amylase gene contains a double promoter acting selectively in parotid gland cells and hepatocytes, as reported by Schibler and co-workers (42) . However, the expression of the a-amylase gene is weak in hepatocytes, whereas the expression of the collagen a I(I) gene is strong in both activated stellate cells and in skin and tendon fibroblasts.
Stellate cells play a key role in the pathogenesis of hepatic fibrosis (4, 5) . Although we (27) and others (36, 37) have reported that quiescent stellate cells produce little collagen type I, activated stellate cells display a high level of collagen a1 (I) gene expression (4, 36, 37) . Therefore, stellate cell activation is essential for hepatic fibrogenesis. Relevant to this study, coculture experiments of hepatocytes and stellate cells treated with CC14 indicate that hepatocytes exert a paracrine stimulation of both lipid peroxidation and collagen gene expression in stellate cells (15) . These results strongly suggest that lipid peroxidation in the absence of inflammation is capable of inducing, directly or indirectly, the expression of collagen a, (I) in stellate cells.
In agreement with our findings, stellate cell collagen gene expression is stimulated by 4-hydroxynonenal, a product of lipid peroxidation (26) .
Analysis of the expression of relevant deleted or mutated 
